The effects of vitamin A supplementation for 3 months on adult rat nigrostriatal axis: Increased monoamine oxidase enzyme activity, mitochondrial redox dysfunction, increased β-amyloid 1-40 peptide and TNF-α contents, and susceptibility of mitochondria to an in vitro H 2O 2 challenge

Brain Research Bulletin

Volumn 87, Issue 4-5, 2012, Pages 432-444

  de Oliveira, Marcos Roberto ^a   da Rocha, Ricardo Fagundes ^a   Pasquali, Matheus Augusto de Bittencourt ^a   Moreira, José Cláudio Fonseca ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

3 Nitrotyrosine; Monoamine oxidase; Striatum; Substantia nigra; Vitamin A

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SYNUCLEIN; AMINE OXIDASE (FLAVIN CONTAINING); AMYLOID BETA PROTEIN[1-40]; BETA SYNUCLEIN; CASPASE 3; CASPASE 8; CYTOCHROME C OXIDASE; DOPAMINE 2 RECEPTOR; GLUCOSE REGULATED PROTEIN 78; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RETINOL; SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; IN VITRO STUDY; MALE; MITOCHONDRIAL ENERGY TRANSFER; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

AMYLOID BETA-PEPTIDES; ANIMALS; CORPUS STRIATUM; DIETARY SUPPLEMENTS; ELECTRON TRANSPORT; HYDROGEN PEROXIDE; MALE; MITOCHONDRIA; MONOAMINE OXIDASE; OXIDANTS; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUBSTANTIA NIGRA; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN A;

EID: 84857921782     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.01.005     Document Type: Article

References (58)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Allen L.H., Haskell M. Estimating the potential for vitamin A toxicity in women and young children. J. Nutr. 2002, 132:2907S-2919S.
3. Bánhegyi G., Mandl J., Csala M. Redox-based endoplamisc reticulum dysfunction in neurological diseases. J. Neurochem. 2008, 107:20-34.
4. Berg D., Youdim M.B.H., Riederer P. Redox imbalance. Cell Tissue Res. 2004, 318:201-213.
5. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
6. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systemic review and meta-analysis. J. Am. Med. Assoc. 2007, 297:842-857.
7. Bjelakovic G., Nikolova D., Gluud L., Simonetti R., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2008, 2:CD007176.
8. Branzzell R.K., Vane F.M., Ehmann C.W., Colburn W.A. Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur. J. Clin. Pharmacol. 1983, 24:695-702.
9. Brownlee M. Negative consequences of glycation. Metabolism 2000, 49:9-13.
10. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M.G. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
11. Cookson M.R., van der Brug M. cell sytems and the toxic mechanism(s) of α-synuclein. Exp. Neurol. 2008, 209:5-11.
12. De Oliveira M.R., Moreira J.C.F. Acute and chronic vitamin A supplementation at therapeutic doses induces oxidative stress to submitochondrial particles isolated from cerebral cortex and cerebellum of adult rats. Toxicol. Lett. 2007, 173:145-150.
13. De Oliveira M.R., Moreira J.C.F. Impaired redox state and respiratory chain enzyme activity activities in the cerebellum of vitamin A-treated rats. Toxicology 2008, 253:125-130.
14. De Oliveira M.R., Silvestrin R.B., Mello e Souza T., Moreira J.C.F. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology 2007, 28:1191-1199.
15. De Oliveira M.R., Pasquali M.A.B., Silvestrin R.B., Mello e Souza T., Moreira J.C.F. Vitamin A supplementation induces a prooxidative state in the striatum and impairs locomotory and exploratory activity of adult rats. Brain Res. 2007, 1169:112-119.
16. De Oliveira M.R., Silvestrin R.B., Mello e Souza T., Moreira J.C.F. Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation. Neurochem. Res. 2008, 33:378-383.
17. De Oliveira M.R., Oliveira M.W.S., Behr G.A., Hoff M.L.M., Da Rocha R.F., Moreira J.C.F. Evaluation of the effects of vitamin A supplementation on adult rat substantia nigra and striatum redox and bioenergetics states: mitochondrial impairment, increased 3-nitrotyrosine and α-synuclein, but decreased D2 receptor contents. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33:353-362.
18. De Oliveira M.R., Oliveira M.W.S., Behr G.A., Moreira J.C.F. Vitamin A supplementation at clinical doses induces a dysfunction in the redox and bioenergetics states, but did not change neither caspases activities nor TNF-alpha levels in the frontal cortex of adult Wistar rats. J. Psychiatr. Res. 2009, 43:754-762.
19. De Oliveira M.R., Oliveira M.W.S., Lorenzi R., da Rocha R.F., Moreira J.C.F. Short-term vitamin A supplementation at therapeutic doses induces a pro-oxidative state in the hepatic environment and facilitates calcium-ion-induced oxidative stress in rat liver mitochondria independently from permeability transition pore formation: detrimental effects of vitamin A supplementation on rat liver redox and bioenergetic states homeostasis. Cell Biol. Toxicol. 2009, 25:545-560.
20. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 186:421-431.
21. Fan Y., Limprasert P., Murria I.V.J., Smith A.C., Lee V.M-Y., Trojanowski J.Q., Sopher B.L., La Spada A.R. β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression. Hum. Mol. Genet. 2006, 15:3002-3011.
22. Fenaux P., Chomienne C., Degos L. Treatment of acute promyelocytic leukaemia. Best Pract. Res. Clin. Haematol. 2001, 14:153-174.
23. Ferguson S.A., Siitonen P.H., Cisneros F.J., Gough B., Young J.F. Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats. Basic Clin. Pharmacol. Toxicol. 2006, 98:582-587.
24. Fischer J.C., Ruitenbeek W., Berden J.Á., Trijbels J.M., Veerkamp J.H., Stadhouders M., Sengers R.C., Janssen A.J. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 1985, 153:23-36.
25. Gelain D.P., de Bittencourt Pasquali M.A., Caregnato F.F., Zanotto-Filho A., Moreira J.C. Retinol up-regulates the receptor for advanced glycation endproducts (RAGE) by increasing intracellular reactive species. Toxicol. In Vitro 2008, 22:1123-1127.
26. Gelain D.P., de Bittencourt Pasquali M.A., Caregnato F.F., Moreira J.C. Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation. Toxicology 2011, 289:38-44.
27. Graham D. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 1978, 14:633-643.
28. Grivennikova V.G., Vinogradov A.D. Generation of superoxide by the mitochondrial Complex I. Biochim. Biophys. Acta 2006, 1757:553-561.
29. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
30. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
31. Hendrix C.W., Jackson K.A., Whitmore E., Guidos A., Kretzer R., Liss C.M., Shah L.P., Khoo K.C., McLane J., Trapnell C.B. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin. Pharmacol. Ther. 2004, 75:464-475.
32. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 401:770-776.
33. Humphrey J.H., Iliff P.J., Marinda E.T., Mutasa K., Moulton L.H., Chidawanyika H., Ward B.J., Nathoo K.J., Malaba L.C., Zijenah L.S., Zvandasara P., Ntozini R., Mzengeva F., Mahomva A.I., Ruff A.J., Mbizvo M.T., Zunzuga C.D., ZVITAMBO Study Group Effects of a single large dose of vitamin A, given during postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J. Infect. Dis. 2006, 193:860-871.
34. Kerr I.G., Lippman M.E., Jenkins J., Myers C.E. Pharmacology of 13-cis-retinoic acid in humans. Cancer Res. 1982, 42:2069-2073.
35. Khan F.H., Sen T., Maiti A.K., Jana S., Chatterjee U., Chakrabarti S. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease. Biochim. Biophys. Acta 2005, 1741:65-74.
36. Klamt F., De Oliveira M.R., Moreira J.C.F. Retinol induces permeability transition and cytochrome c release from rat liver mitochondria. Biochim. Biophys. Acta 2005, 1726:14-20.
37. Kono Y., Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982, 257:5751-5754.
38. Lotharius J., Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein. Nat. Rev. Neurosci. 2002, 3:932-942.
39. Lowry O.H., Rosebrough A.L., Randal R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
40. Maker H.S., Weiss C., Slides D.J., Cohen G. Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 1981, 36:589-593.
41. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
42. Mosharov E.V., Staal R.G.W., Bové J., Prou D., Hananiya A., Markov D., Poulsen N., Larsen K.E., Moore C.M.H., Troyer M.D., Edwards R.H., Przedborski S., Sulzer D. α-Synuclein overexpression increases cytosolic catecholamine concentration. J. Neurosci. 2006, 26:9304-9311.
43. Myhre A.M., Carlsen M.H., Bohn S.K., Wold H.L., Laake P., Blomhoff R. Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations. Am. J. Clin. Nutr. 2003, 78:1152-1159.
44. Nulman I., Berkovitch M., Klein J., Pastuszak A., Lester R.S., Shear N., Koren G. Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. J. Clin. Pharmacol. 1998, 38:926-930.
45. O'Reilly K., Bailey S.J., Lane M.A. Retinoid-mediated regulation of mood: possible cellular mechanisms. Exp. Biol. Med. 2008, 233:251-258.
46. Palace V.P., Khaper P., Qin Q., Singal P.K. Antioxidant potential of vitamin A and carotenoids and their relevance to heart disease. Free Radic. Biol. Med. 1999, 26:746-761.
47. Paschen W., Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 2005, 38:409-415.
48. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 1996, 328:85-92.
49. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994, 228:35-51.
50. Shapira A.H., Mann V.M., Cooper J.M., Dexter D., Daniel S.E., Jenner P., Clark J.B., Marsden C.D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 1990, 55:2142-2145.
51. Sheehan D., Meade G., Foley V.M., Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360:1-16.
52. Shimizu N., Kobayashi K., Hayashi K. The reaction of superoxide radical with catalase. J. Biol. Chem. 1984, 259:4414-4418.
53. Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 2003, 278:11753-11759.
54. Souza J.M., Peluffo G., Radi R. Protein tyrosine nitration-functional alteration or just a biomarker. Free Radic. Biol. Med. 2008, 45:357-366.
55. Strassburger M., Bloch W., Sulyok S., Schuller J., Keist A.F., Schmidt A., Wenk J., Peters T., Wlaschek M., Krieg T., Hafner M., Kümin A., Werner S., Müller W., Scharffetter-Kochanek K. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic. Biol. Med. 2005, 38:1458-1470.
56. Tsunati H., Iwasaki H., Kawai Y., Tanaka T., Ueda T., Uchida M., Nakamura T. Reduction of leukemia cell growth in a patient with acute promyelocytic leukemia treated by retinol palmitate. Leukemia Res 1990, 14:595-600.
57. Tsunati H., Ueda T., Uchida M., Nakamura T. Pharmacological studies of retinol palmitate and its clinical effect in patients with acute non-lymphocytic leukemia. Leukemia Res. 1991, 15:463-471.
58. Weissbach H., Smith T.E., Daly J.W., Witkop B., Udenfriend S. A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kynuramine. J. Biol. Chem. 1960, 235:1160-1163.